Guru Ownership Over Time
Guru Analysis for Agios Pharmaceuticals, Inc. (AGIO)
Agios Pharmaceuticals, Inc. (AGIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $27.48 M.
Top institutional holders include Ken Fisher and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.25 M net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Louis Moore Bacon reduced exposure by 31.3%.
| Portfolio Manager | % of portfolio | Activity | Shares | Value | Peroid |
|---|---|---|---|---|---|
| 0.01% | Reduce -0.8% | 870,145 | $34.93 M | Q3 2025 | |
| 0.00% | Reduce -5.4% | 91,635 | $3.61 M | Q3 2025 | |
| 0.03% | Reduce -31.3% | 55,000 | $2.21 M | Q3 2025 | |
| 0.00% | New Buy | 6,507 | $261,190 | Q3 2025 |
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Period | Portfolio Manager | Activity | Share change | % change to portfolio |
|---|
| Portfolio Manager | Option Type | % of portfolio | Activity | Shares | Value | Period |
|---|
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown(Q3 2025)
Guru Consensus (Q3 2025)
FAQs for Agios Pharmaceuticals, Inc. (AGIO)
Top Guru holders include Ken Fisher ($34.93 M), Cliff Asness ($3.61 M), Louis Moore Bacon ($2.21 M). Collectively, tracked Gurus hold 1.02 M shares.
Based on recent 13F filings, the sentiment is **Negative (Net Sell)**. There was a net outflow of $1.25 M, with 1 Gurus buying and 3 Gurus selling.
In the recent quarter, 3 Gurus reduced their positions, and 0 Gurus sold out of AGIO completely. Total sell value was $1.51 M.
Yes, 1 Gurus opened new positions in AGIO, and 0 added to their existing holdings. Total buy value was $261,190.